Combination of copeptin, placental growth factor and total annexin V microparticles for prediction of preeclampsia at 10-14 weeks of gestation.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Placenta

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.placenta.2017.08.009PMID 28962698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vasopressin in Preeclampsia: A Novel Very Early Human Pregnancy Biomarker and Clinically Relevant Mouse Model

  2014cited by this paper
• Increased Levels of Copeptin Before Clinical Diagnosis of Preeclampsia

  2014cited by this paper
• Hormones and Hemodynamics in Pregnancy

  2014cited by this paper
• Prevention of perinatal death and adverse perinatal outcome using low‐dose aspirin: a meta‐analysis

  2013cited by this paper
• Elevated Procoagulant Endothelial and Tissue Factor Expressing Microparticles in Women with Recurrent Pregnancy Loss

  2013cited by this paper
• First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia

  2013cited by this paper
• Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy.

  2012cited by this paper
• Vasopressin V1a and V1b receptors: from molecules to physiological systems.

  2012cited by this paper
• Circulating microparticles in severe preeclampsia.

  2012cited by this paper
• New markers in preeclampsia.

  2010cited by this paper
• Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange

  2010cited by this paper
• Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop

  2010cited by this paper
• Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis

  2010cited by this paper
• Copeptin is a strong and independent predictor of outcome in cardiogenic shock

  2009cited by this paper
• Placental Origins of Preeclampsia: Challenging the Current Hypothesis

  2008cited by this paper
• Changes in Microparticle Numbers and Cellular Origin During Pregnancy and Preeclampsia

  2008cited by this paper
• Intrauterine restriction (IUGR)

  2008cited by this paper
• Circulating microparticles in normal pregnancy and pre-eclampsia.

  2008cited by this paper
• Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication

  2006cited by this paper
• WHO analysis of causes of maternal death: a systematic review.

  2006cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

  2006cited by this paper
• The role of RAS in the pathogenesis of preeclampsia

  2006cited by this paper
• V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity

  2006cited by this paper
• Management of pre-eclampsia

  2006cited by this paper
• Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

  2005cited by this paper
• Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients.

  2005cited by this paper
• Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study.

  2005cited by this paper
• Antibiotic use in relation to the risk of breast cancer

  2004cited by this paper
• Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension.

  2004cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies.

  2003cited by this paper
• Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women.

  2003cited by this paper
• Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

  2003cited by this paper
• Elevated plasma endothelial microparticles in preeclampsia.

  2003cited by this paper
• Recent Insights into the pathogenesis of pre-eclampsia.

  2002cited by this paper
• Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction?

  2002cited by this paper
• Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women.

  2002cited by this paper
• Vasopressin receptor antagonism — a therapeutic option in heart failure and hypertension

  2000cited by this paper
• The management of pre‐eclampsia

  2000cited by this paper
• Pre-eclampsia

  2000cited by this paper
• Vasopressin receptors in human adrenal medulla and pheochromocytoma.

  1999cited by this paper
• Preeclampsia is associated with reduced serum levels of placenta growth factor.

  1998cited by this paper
• Role of vasopressin in essential hypertension: Racial differences

  1997cited by this paper
• Hypertension in pregnancy

  1996cited by this paper
• Osmoregulation of thirst and vasopressin release in severe chronic renal failure.

  1991cited by this paper
• Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy.

  1983cited by this paper
• THE ULTRASTRUCTURE OF THE ARTERIAL SUPPLY OF THE HUMAN PLACENTA IN PREGNANCY COMPLICATED BY FETAL GROWTH RETARDATION

  1976cited by this paper
• A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization.

  1972cited by this paper
• A glycopeptide from the posterior lobe of pig pituitaries. 2. Primary structure.

  1972cited by this paper

• Extracellular Vesicles and Pregnancy-Related Hypertensive Disorders: A Descriptive Review on the Possible Implications “From Bench to Bedside”

  2025cites this paper
• Extracellular Vesicles as Biomarkers of Pregnancy Complications

  2024cites this paper
• Infertility: Focus on the therapeutic potential of extracellular vesicles

  2024cites this paper
• Neurodevelopmental Disruptions in Children of Preeclamptic Mothers: Pathophysiological Mechanisms and Consequences

  2024cites this paper
• Circulating extracellular vesicles in healthy and pathological pregnancies: A scoping review of methodology, rigour and results

  2023cites this paper
• Advances in extracellular vesicles as mediators of cell-to-cell communication in pregnancy.

  2023cites this paper
• The implications of exosomes in pregnancy: emerging as new diagnostic markers and therapeutics targets

  2022cites this paper
• Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia

  2022cites this paper
• Prediction performance of serum placental growth factor (PLGF) human chorionic gonadotropin β (β-hCG) and PAPP-A levels in early pregnancy for pregnancy outcomes

  2022cites this paper
• Echocardiography with tissue Doppler imaging may help in bedside differential diagnosis of pulmonary oedema in pregnancy: case report

  2022cites this paper
• Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway

  2021cites this paper
• Overview of extracellular vesicles in the pathogenesis of preeclampsia†

  2021cites this paper
• Extracellular Vesicles and Preeclampsia: Current Knowledge and Future Research Directions.

  2021cites this paper
• The Role and Clinical Interest of Extracellular Vesicles in Pregnancy and Ovarian Cancer

  2021cites this paper
• Fetal Storage of Osmotically Inactive Sodium.

  2020cites this paper
• Renal biomarkers of preeclampsia

  2020cites this paper
• Exosomes as Messengers between Mother and Fetus in Pregnancy

  2020cites this paper
• Association between serum copeptin levels and preeclampsia risk: A meta-analysis.

  2020cites this paper
• Inside(sight) of tiny communicator: exosome biogenesis, secretion, and uptake

  2020cites this paper
• Serum Copeptin Levels in Threatened Preterm Labor

  2020cites this paper
• Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy

  2019cites this paper
• Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Protects From Angiotensin II-Induced Endothelial Dysfunction in Adult Offspring Born From Pregnancies Complicated by Hypertension.

  2019cites this paper
• Prior exposure to placental ischemia causes increased salt sensitivity of blood pressure via vasopressin production and secretion in postpartum rats.

  2019cites this paper
• Copeptin in Preeclampsia Development

  2019cites this paper
• Cell-Derived Microparticles (MPs) and their Role in Unexplained Recurrent Pregnancy Loss

  2018cites this paper
• Proteomics Analysis Reveals Abnormal Electron Transport and Excessive Oxidative Stress Cause Mitochondrial Dysfunction in Placental Tissues of Early‐Onset Preeclampsia

  2018cites this paper
• Effects of placental growth factor deficiency on behavior, neuroanatomy, and cerebrovasculature of mice.

  2018cites this paper
• Increase in regional oxygen saturation in the thigh indicates successful block of the femoral nerve after lumbar plexus block.

  2018cites this paper